Effective targeted gene knockdown in mammalian cells using the piggyBac transposase-based delivery system

Molecular Therapy Nucleic Acids

Volumn 2, Issue DEC, 2013, Pages e137-

  Owens, Jesse B ^a   Mathews, Juanita ^a   Davy, Philip ^a   Stoytchev, Ilko ^a   Moisyadi, Stefan ^a   Allsopp, Rich ^a  

^a UNIVERSITY OF HAWAII   (United States)

Author keywords

Cell line; PiggyBac transposase; PmGENIE 3; RNA interference; Telomerase

Indexed keywords

ANTIBIOTIC AGENT; PIGGYBAC TRANSPOSASE; SHORT HAIRPIN RNA; TELOMERASE; TELOMERASE REVERSE TRANSCRIPTASE; TRANSPOSASE; UNCLASSIFIED DRUG;

ANIMAL CELL; ANIMAL EXPERIMENT; ARTICLE; CELL PROLIFERATION; CELL VIABILITY; CONTROLLED STUDY; EXPRESSION VECTOR; GENE EXPRESSION; GENE SILENCING; GENE TARGETING; GENE TRANSFER; GENE VECTOR; GENETIC TRANSFECTION; HEK293 CELL LINE; HUMAN; HUMAN CELL; IMMORTALIZED CELL LINE; INTEGRATION; MAMMAL CELL; MCF 7 CELL LINE; MOUSE; NONHUMAN; NONVIRAL GENE DELIVERY SYSTEM; PRIORITY JOURNAL; TELOMERE;

EID: 84907049048     PISSN: None     EISSN: 21622531     Source Type: Journal    
DOI: 10.1038/mtna.2013.61     Document Type: Article

References (35)

1. Katter, K, Geurts, AM, Hoffmann, O, Mátés, L, Landa, V, Hiripi, L et al. (2013). Transposon-mediated transgenesis, transgenic rescue, and tissue-specific gene expression in rodents and rabbits. FASEB J 27:930-941.
2. Daniel, R and Smith, JA (2008). Integration site selection by retroviral vectors: molecular mechanism and clinical consequences. Hum Gene Ther 19:557-568.
3. Di Matteo, M, Belay, E, Chuah, MK and Vandendriessche, T (2012). Recent developments in transposon-mediated gene therapy. Expert Opin Biol Ther 12:841-858.
4. Mitchell, RS, Beitzel, BF, Schroder, AR, Shinn, P, Chen, H, Berry, CC et al. (2004). Retroviral DNA integration: ASLV, HIV, and MLV show distinct target site preferences. PLoS Biol 2: E234.
5. Muruve, DA, Barnes, MJ, Stillman, IE and Libermann, TA (1999). Adenoviral gene therapy leads to rapid induction of multiple chemokines and acute neutrophil-dependent hepatic injury in vivo. Hum Gene Ther 10:965-976.
6. Wu, X, Li, Y, Crise, B and Burgess, SM (2003). Transcription start regions in the human genome are favored targets for MLV integration. Science 300:1749-1751.
7. Kay, MA, Glorioso, JC and Naldini, L (2001). Viral vectors for gene therapy: the art of turning infectious agents into vehicles of therapeutics. Nat Med 7:33-40.
8. Ivics, Z, Hackett, PB, Plasterk, RH and Izsvák, Z (1997). Molecular reconstruction of Sleeping Beauty, a Tc1-like transposon from fish, and its transposition in human cells. Cell 91:501-510.
9. Ivics, Z and Izsvák, Z (2011). Nonviral gene delivery with the sleeping beauty transposon system. Hum Gene Ther 22:1043-1051.
10. Izsvák, Z and Ivics, Z (2004). Sleeping beauty transposition: biology and applications for molecular therapy. Mol Ther 9:147-156.
11. Shinohara, ET, Kaminski, JM, Segal, DJ, Pelczar, P, Kolhe, R, Ryan, T et al. (2007). Active integration: new strategies for transgenesis. Transgenic Res 16:333-339.
12. Wu, SC, Meir, YJ, Coates, CJ, Handler, AM, Pelczar, P, Moisyadi, S et al. (2006). piggyBac is a flexible and highly active transposon as compared to sleeping beauty, Tol2, and Mos1 in mammalian cells. Proc Natl Acad Sci USA 103:15008-15013.
13. Ding, S, Wu, X, Li, G, Han, M, Zhuang, Y and Xu, T (2005). Efficient transposition of the piggyBac (PB) transposon in mammalian cells and mice. Cell 122:473-483.
14. Feschotte, C (2006). The piggyBac transposon holds promise for human gene therapy. Proc Natl Acad Sci USA 103:14981-14982.
15. Saridey, SK, Liu, L, Doherty, JE, Kaja, A, Galvan, DL, Fletcher, BS et al. (2009). PiggyBac transposon-based inducible gene expression in vivo after somatic cell gene transfer. Mol Ther 17:2115-2120.
16. Urschitz, J, Kawasumi, M, Owens, J, Morozumi, K, Yamashiro, H, Stoytchev, I et al. (2010). Helper-independent piggyBac plasmids for gene delivery approaches: strategies for avoiding potential genotoxic effects. Proc Natl Acad Sci USA 107:8117-8122.
17. Li, MA, Turner, DJ, Ning, Z, Yusa, K, Liang, Q, Eckert, S et al. (2011). Mobilization of giant piggyBac transposons in the mouse genome. Nucleic Acids Res 39:e148.
18. Fraser, MJ, Ciszczon, T, Elick, T and Bauser, C (1996). Precise excision of TTAA-specific lepidopteran transposons piggyBac (IFP2) and tagalong (TFP3) from the baculovirus genome in cell lines from two species of Lepidoptera. Insect Mol Biol 5:141-151.
19. Yusa, K, Rad, R, Takeda, J and Bradley, A (2009). Generation of transgene-free induced pluripotent mouse stem cells by the piggyBac transposon. Nat Methods 6:363-369.
20. Owens, JB, Urschitz, J, Stoytchev, I, Dang, NC, Stoytcheva, Z, Belcaid, M et al. (2012). Chimeric piggyBac transposases for genomic targeting in human cells. Nucleic Acids Res 40:6978-6991.
21. Kim, NW, Piatyszek, MA, Prowse, KR, Harley, CB, West, MD, Ho, PL et al. (1994). Specific association of human telomerase activity with immortal cells and cancer. Science 266:2011-2015.
22. Nakamura, TM, Morin, GB, Chapman, KB, Weinrich, SL, Andrews, WH, Lingner, J et al. (1997). Telomerase catalytic subunit homologs from fission yeast and human. Science 277:955-959.
23. Bodnar, AG, Ouellette, M, Frolkis, M, Holt, SE, Chiu, CP, Morin, GB et al. (1998). Extension of life-span by introduction of telomerase into normal human cells. Science 279:349-352.
24. Marh, J, Stoytcheva, Z, Urschitz, J, Sugawara, A, Yamashiro, H, Owens, JB et al. (2012). Hyperactive self-inactivating piggyBac for transposase-enhanced pronuclear microinjection transgenesis. Proc Natl Acad Sci USA 109:19184-19189.
25. Harley, CB, Futcher, AB and Greider, CW (1990). Telomeres shorten during ageing of human fibroblasts. Nature 345:458-460.
26. Allsopp, RC and Harley, CB (1995). Evidence for a critical telomere length in senescent human fibroblasts. Exp Cell Res 219:130-136.
27. Galvan, DL, Nakazawa, Y, Kaja, A, Kettlun, C, Cooper, LJ, Rooney, CM et al. (2009). Genome-wide mapping of PiggyBac transposon integrations in primary human T cells. J Immunother 32:837-844.
28. Boudreau, RL and Davidson, BL (2012). Generation of hairpin-based RNAi vectors for biological and therapeutic application. Meth Enzymol 507:275-296.
29. Zaffaroni, N, Pennati, M and Folini, M (2007). Validation of telomerase and survivin as anticancer therapeutic targets using ribozymes and small-interfering RNAs. Methods Mol Biol 361:239-263.
30. Dikmen, ZG, Gellert, GC, Jackson, S, Gryaznov, S, Tressler, R, Dogan, P et al. (2005). In vivo inhibition of lung cancer by GRN163L: a novel human telomerase inhibitor. Cancer Res 65:7866-7873.
31. Woltjen, K, Michael, IP, Mohseni, P, Desai, R, Mileikovsky, M, Hämäläinen, R et al. (2009). piggyBac transposition reprograms fibroblasts to induced pluripotent stem cells. Nature 458:766-770.
32. Livak, KJ and Schmittgen, TD (2001). Analysis of relative gene expression data using realtime quantitative PCR and the 2 (-Delta Delta C (T)) Method. Methods 25:402-408.
33. Zhu, CQ, Cutz, JC, Liu, N, Lau, D, Shepherd, FA, Squire, JA et al. (2006). Amplification of telomerase (hTERT) gene is a poor prognostic marker in non-small-cell lung cancer. Br J Cancer 94:1452-1459.
34. Vandesompele, J, De Preter, K, Pattyn, F, Poppe, B, Van Roy, N, De Paepe, A et al. (2002). Accurate normalization of real-time quantitative RT-PCR data by geometric averaging of multiple internal control genes. Genome Biol 3:RESEARCH0034.
35. Vaziri, H, Schächter, F, Uchida, I, Wei, L, Zhu, X, Effros, R et al. (1993). Loss of telomeric DNA during aging of normal and trisomy 21 human lymphocytes. Am J Hum Genet 52:661-667.